Sars Cov@ Rapid Antigen Test

SARS-CoV-2 Rapid Antigen Test Nasal

9901-NCOV-03G 25 Tests/Kit
EUR 112.8
Description: The SARS-CoV-2 Rapid Antigen Test is a lateral fl ow rapid chromatographic immunoassay for the qualitative detection of nucleocapsid antigen to SARS-CoV-2 present in human nasal samples. This test is intended for use as an aid in detection of SARS-CoV-2 infection in individuals suspected of COVID-19 with clinical symptoms onset within 5 days. Results are for the identification of SARS-CoV-2 nucleocapsid antigen. Antigen is generally detectable in human nasal swab samples during the acute phase of infection. Positive results indicate the presence of viral antigens, but clinical correlation with patient history and other diagnostic information is necessary to determine infection status. Positive results do not rule out bacterial infection or co- infection with other viruses. The agent detected may not be the definite cause of disease. Negative results should be treated as presumptive, and do not rule out SARS-CoV-2 infection and should not be used as the sole basis for treatment or patient management decisions, including infection control decisions. Negative results should be considered in the context of a patient’s recent exposures, history and the presence of clinical signs and symptoms consistent with COVID-19, and confirmed with a molecular assay, if necessary, for patient management. The SARS-CoV-2 Rapid Antigen Test is intended for use in laboratory or POC settings by healthcare professionals, or self-collection under the supervision of a healthcare worke

Human IgG antibody Laboratories manufactures the sars cov@ rapid antigen test reagents distributed by Genprice. The Sars Cov@ Rapid Antigen Test reagent is RUO (Research Use Only) to test human serum or cell culture lab samples. To purchase these products, for the MSDS, Data Sheet, protocol, storage conditions/temperature or for the concentration, please contact SARS Test. Other Sars products are available in stock. Specificity: Sars Category: Cov@ Group: Rapid Antigen

Human Mycobacterium Tuberculosis (MT) IgG Rapid Test Kit

20 tests
EUR 276

Human Helicobacter Pylori (HP) IgG Rapid Test Kit

20 tests
EUR 276

Human Hantavirus (HV) IgM / IgG Rapid Test Kit

20 tests
EUR 326.4

Human Rubella Virus (RV) IgG Rapid Test Kit

20 tests
EUR 260.4

Human Rabies Virus (HRV) IgG Rapid Test Kit

20 tests
EUR 410.4

Human Chlamydia Pneumoniae (CP) IgG Rapid Test Kit

20 tests
EUR 309.6

Human Mycoplasma Pneumoniae (MP) IgG Rapid Test Kit

20 tests
EUR 309.6

Rapid Antigen information

Panbio™ COVID-19 Ag Rapid Test Device

41FK10 25 Tests/Kit
EUR 115.2

Melamine (MEL) Rapid Test Kit

abx092057-50tests 50 tests
EUR 444

TruStrip RDT Zaire Ebola Virus antigen (GP) rapid test (visual results in 2-10 mins), 10 cassettes/pk

AE-320805-RDT-10 1 pk
EUR 343.2

Salbutamol (SAL) Rapid Test Kit

abx092060-50tests 50 tests
EUR 292.8

Quinolones (QNs) Rapid Test Kit

abx092065-40tests 40 tests
EUR 477.6

Quinolones (QNs) Rapid Test Kit

abx092067-40tests 40 tests
EUR 477.6

Clenbuterol (CLE) Rapid Test Kit

abx092058-50tests 50 tests
EUR 292.8

Ractopamine (RAC) Rapid Test Kit

abx092059-50tests 50 tests
EUR 292.8

Tetracycline (TCs) Rapid Test Kit

abx092063-50tests 50 tests
EUR 477.6

Sulfonamides (Sas) Rapid Test Kit

abx092064-40tests 40 tests
EUR 477.6

Cow Brucella Antibody Rapid Test Kit

abx092071-40tests 40 tests
EUR 427.2

Goat Brucella Antibody Rapid Test Kit

abx092070-40tests 40 tests
EUR 427.2

Ciprofloxacin (CPFX) Rapid Test Kit

abx092066-50tests 50 tests
EUR 477.6

Pig Parvovirus Antibody Rapid Test Kit

abx092074-50tests 50 tests
EUR 385.2

Panbio™ COVID-19 Ag Rapid Test Device (Nasal)

41FK11 25 Tests/Kit
EUR 128
Description: The Coronavirus disease (COVID-19) is an infectious disease caused by a newly discovered coronavirus, severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). The SARS-CoV-2 is a β -coronavirus, which is an enveloped non-segmented positive-sense RNA virus 2. It is spread by human-to-human transmission via droplets or direct contact, and infection has been estimated to have a mean incubation period of 6.4 days and a basic reproduction number of 2.24-3.58. Among patients with pneumonia caused by SARS-CoV-2, fever was the most common symptom, followed by cough3. The main IVD assays used for COVID-19 employ real-time reverse transcriptase-polymerase chain reaction (RT-PCR) that takes a few hours 4. The availability of a cost-effective, rapid point- of-care diagnostic test is critical to enable healthcare professionals to aid in the diagnosis of patients and prevent further spread of the virus5. Antigen tests will play a critical role in the fight against COVID-19

TruStrip RDT Canine distemper virus (hardpad disease) antigen rapid test card, results is 2-10 mins, 50 cards/pk

RV-501200-RDT 1 pk Ask for price

Procalcitonin rapid test (Colloidal Gold)

abx095264-80Units 80 Units
EUR 1144.8